HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John C Morris Selected Research

5- carboxy- methylaminomethyl- 2'- O- methyluridine

11/2002Pharmacokinetics and organ distribution of N-methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John C Morris Research Topics

Disease

259Alzheimer Disease (Alzheimer's Disease)
10/2022 - 02/2002
95Neoplasms (Cancer)
05/2022 - 06/2002
77Dementia (Dementias)
11/2022 - 07/2002
64Cognitive Dysfunction
11/2022 - 02/2002
31Disease Progression
05/2022 - 12/2006
31Atrophy
01/2022 - 08/2005
18Amyloidosis
01/2022 - 12/2009
17Amyloid Plaque
07/2021 - 10/2004
15Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 07/2003
13Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2017 - 11/2004
12Inflammation (Inflammations)
04/2022 - 10/2014
12Neuroinflammatory Diseases
02/2022 - 11/2010
11Tauopathies
02/2022 - 01/2016
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2008
10Breast Neoplasms (Breast Cancer)
07/2011 - 05/2004
9Neoplasm Metastasis (Metastasis)
11/2020 - 04/2008
9Squamous Cell Carcinoma of Head and Neck
01/2020 - 09/2005
9Prostatic Neoplasms (Prostate Cancer)
12/2018 - 11/2003
8medullary Thyroid cancer
01/2022 - 06/2004
8Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
05/2011 - 09/2006
7Anaplastic Thyroid Carcinoma
03/2022 - 10/2010
7Cerebral Cortical Thinning
01/2020 - 03/2009
6Pheochromocytoma
05/2022 - 04/2008
6Parkinson Disease (Parkinson's Disease)
01/2021 - 07/2015
6Carcinoma (Carcinomatosis)
01/2020 - 11/2004
6Lung Neoplasms (Lung Cancer)
01/2019 - 05/2013
6Frontotemporal Dementia (Semantic Dementia)
05/2011 - 09/2006
5Hypertension (High Blood Pressure)
05/2022 - 05/2014
5Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2014
5Infections
09/2012 - 11/2003
5Head and Neck Neoplasms (Head and Neck Cancer)
06/2010 - 01/2002
4Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
10/2021 - 10/2019
4Neurobehavioral Manifestations
01/2021 - 03/2012
4Proteostasis Deficiencies
11/2018 - 01/2008
4Neutropenia
10/2018 - 05/2010
4Melanoma (Melanoma, Malignant)
04/2015 - 01/2002
4Leukemia
03/2013 - 04/2009
3Paraganglioma (Paragangliomas)
05/2022 - 08/2009
3Graves Disease (Basedow Disease)
10/2021 - 09/2002
3Diarrhea
01/2020 - 05/2014
3Gliosis
01/2020 - 01/2007
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2019 - 01/2011
3Thyroid Nodule (Nodule, Thyroid)
01/2018 - 09/2002
3Fatigue
01/2017 - 10/2010

Drug/Important Bio-Agent (IBA)

162Biomarkers (Surrogate Marker)IBA
11/2022 - 07/2002
143Amyloid (Amyloid Fibrils)IBA
10/2022 - 07/2002
34Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
32Apolipoproteins E (ApoE)IBA
01/2022 - 01/2010
30Amyloid beta-PeptidesIBA
02/2022 - 12/2003
172- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
10/2021 - 11/2008
17sodium-iodide symporter (sodium iodide symporter)IBA
10/2014 - 11/2003
15ApolipoproteinsIBA
01/2022 - 07/2002
15IodidesIBA
06/2010 - 11/2002
14VaccinesIBA
01/2021 - 03/2004
13Monoclonal AntibodiesIBA
10/2021 - 01/2006
11Biological ProductsIBA
07/2021 - 06/2007
9CytokinesIBA
01/2020 - 09/2005
9AntibodiesIBA
10/2019 - 11/2004
9Pharmaceutical PreparationsIBA
01/2017 - 11/2002
8Peptides (Polypeptides)IBA
02/2022 - 05/2007
8AntigensIBA
12/2018 - 09/2002
7Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 09/2015
7Apolipoprotein E4IBA
01/2021 - 12/2010
7Glucose (Dextrose)FDA LinkGeneric
12/2020 - 03/2008
7EnzymesIBA
01/2020 - 11/2002
6Therapeutic UsesIBA
10/2021 - 10/2007
6tau Proteins (tau Protein)IBA
01/2020 - 07/2002
6IodineIBA
01/2020 - 11/2007
6ProgranulinsIBA
12/2018 - 09/2006
6DNA-Binding Proteins (DNA Binding Protein)IBA
11/2018 - 07/2007
6Alemtuzumab (Campath)FDA Link
01/2017 - 04/2008
6Interleukin-15 (Interleukin 15)IBA
01/2015 - 01/2006
6Radioisotopes (Radionuclides)IBA
09/2012 - 12/2004
5Threonine (L-Threonine)FDA Link
01/2022 - 05/2009
5Presenilin-1IBA
01/2018 - 12/2005
5Indicators and Reagents (Reagents)IBA
01/2016 - 09/2006
4NeurograninIBA
01/2021 - 11/2015
4LipidsIBA
01/2021 - 08/2002
4Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2019 - 11/2005
4UbiquitinIBA
04/2008 - 09/2006
4Thymidine KinaseIBA
08/2007 - 06/2002
3lenvatinibIBA
05/2022 - 10/2017
3Thyrotropin Receptors (Thyrotropin Receptor)IBA
10/2021 - 09/2002
3Ethanol (Ethyl Alcohol)IBA
09/2021 - 06/2014
3Dopamine (Intropin)FDA LinkGeneric
01/2021 - 01/2020
3Thyroxine (Levothyroxine)FDA LinkGeneric
12/2019 - 06/2004
3B7-H1 AntigenIBA
10/2019 - 12/2010
3Carrier Proteins (Binding Protein)IBA
01/2019 - 03/2005
3Prostate-Specific Antigen (Semenogelase)IBA
12/2018 - 11/2007
3EpitopesIBA
12/2018 - 06/2007
37- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2018 - 04/2017
3ThyroglobulinFDA Link
10/2017 - 07/2003
3IsotopesIBA
08/2017 - 07/2003
3cabazitaxelFDA Link
02/2017 - 12/2014

Therapy/Procedure

84Therapeutics
02/2022 - 09/2002
14Radiotherapy
03/2022 - 07/2003
11Immunotherapy
07/2020 - 06/2004
10Drug Therapy (Chemotherapy)
01/2022 - 06/2004
3Chemoradiotherapy
03/2022 - 07/2009
3Intravenous Injections
08/2017 - 03/2004